Yongjie Bai

ORCID: 0000-0002-5650-4377
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Cerebrovascular and Carotid Artery Diseases
  • Stroke Rehabilitation and Recovery
  • Venous Thromboembolism Diagnosis and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Blockchain Technology Applications and Security
  • COVID-19 and healthcare impacts
  • Lipid metabolism and disorders
  • Nuclear Receptors and Signaling
  • Apelin-related biomedical research
  • Genetics and Neurodevelopmental Disorders
  • Climate Change and Health Impacts
  • Retinal and Optic Conditions
  • Cardiovascular, Neuropeptides, and Oxidative Stress Research
  • Nanocluster Synthesis and Applications
  • Cloud Computing and Resource Management
  • IL-33, ST2, and ILC Pathways
  • Carbon and Quantum Dots Applications
  • RNA Interference and Gene Delivery
  • Sarcoidosis and Beryllium Toxicity Research
  • Parathyroid Disorders and Treatments
  • Heme Oxygenase-1 and Carbon Monoxide
  • Robotics and Automated Systems
  • Ginseng Biological Effects and Applications
  • Graph Theory and Algorithms

First Affiliated Hospital of Henan University of Science and Technology
2014-2024

Wenzhou Medical University
2024

Clinical Trial Investigators
2024

Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University
2024

Huawei Technologies (China)
2023-2024

Taiyuan Normal University
2023

Nanjing Medical University
2017-2020

Nanjing General Hospital of Nanjing Military Command
2017-2019

Henan University of Science and Technology
2015-2019

Zhengzhou People's Hospital
2017

<h3>Importance</h3> For patients with large vessel occlusion strokes, it is unknown whether endovascular treatment alone compared intravenous thrombolysis plus (standard treatment) can achieve similar functional outcomes. <h3>Objective</h3> To investigate thrombectomy noninferior to alteplase followed by for achieving independence at 90 days among stroke. <h3>Design, Setting, and Participants</h3> Multicenter, randomized, noninferiority trial conducted 33 stroke centers in China. Patients (n...

10.1001/jama.2020.23523 article EN JAMA 2021-01-19

<h3>Importance</h3> Several randomized clinical trials have recently established the safety and efficacy of endovascular treatment (EVT) acute ischemic stroke in anterior circulation. However, it remains uncertain whether patients with basilar artery occlusion (BAO) benefit from EVT. <h3>Objective</h3> To evaluate association between EVT outcomes BAO. <h3>Design, Setting, Participants</h3> This nonrandomized cohort study, for Acute Basilar Artery Occlusion Study (BASILAR) was a nationwide...

10.1001/jamaneurol.2020.0156 article EN JAMA Neurology 2020-02-21

Embodied Artificial Intelligence (Embodied AI) is crucial for achieving General (AGI) and serves as a foundation various applications that bridge cyberspace the physical world. Recently, emergence of Multi-modal Large Models (MLMs) World (WMs) have attracted significant attention due to their remarkable perception, interaction, reasoning capabilities, making them promising architecture brain embodied agents. However, there no comprehensive survey AI in era MLMs. In this survey, we give...

10.48550/arxiv.2407.06886 preprint EN arXiv (Cornell University) 2024-07-09

BACKGROUND: The present study aimed to evaluate the efficacy and safety of intravenous tirofiban versus alteplase before endovascular treatment (EVT) in acute ischemic stroke patients with intracranial large vessel occlusion. METHODS: This was a post hoc analysis using data from 2 multicenter, randomized trials: DEVT trial (Direct Endovascular Treatment for Large Vessel Occlusion Stroke) May 2018 2020 RESCUE BT (Intravenous Tirofiban Before Thrombectomy Acute Ischemic October 2021. Patients...

10.1161/strokeaha.123.044562 article EN Stroke 2024-04-01

Background and purpose The aim of the study was to evaluate whether leukoaraiosis severity is associated with outcome in acute stroke patients undergoing mechanical thrombectomy stent-retriever devices. Methods In this retrospective multicenter study, we evaluated 251 (pretreatment National Institutes Health Stroke Scale score ≥8) treated Leukoaraiosis graded as 0–2 (absent-to-moderate) versus 3–4 (severe) according van Swieten scale. main clinical proportion good functional outcome, defined...

10.1136/neurintsurg-2018-014018 article EN Journal of NeuroInterventional Surgery 2018-07-24

Social distance, quarantine, pathogen testing, and other preventive strategies implemented during CO-VID-19 pandemic may negatively influence the management of acute ischemic stroke (AIS).The current study aimed to evaluate impacts COVID-19 on treatment delay AIS in China.This included patients with admitted 2 hospitals Jiangsu, China. Patients before after outbreak (January 31, 2020, as officially announced by Chinese government) were screened collect sociodemographic data, medical history...

10.1159/000517075 article EN other-oa Cerebrovascular Diseases 2021-01-01

The inflammatory response plays a vital role in the development of in-stent restenosis (ISR) after carotid angioplasty and stenting (CAS). neutrophil to lymphocyte ratio (NLR) has been suggested as sensitive marker. We explored association between NLR ISR CAS patients. A total 427 patients who underwent were enrolled. Neutrophil was measured before procedure. Clinical examination radiographic evaluation performed at 6 months annually In-stent defined ≥50% stenosis treated lesion. Cox...

10.1177/0003319718784805 article EN Angiology 2018-06-25

Magnetic nanoparticles SPIONs are non-invasively introduced into the brain to enhance effects of a non-invasive clinical stimulation method for treating neurological disorders.

10.1039/c9bm00178f article EN Biomaterials Science 2019-01-01

Preventive strategies implemented during the COVID-19 pandemic may negatively influence management of patients with acute ischemic stroke (AIS). Nowadays, studies have demonstrated that has led to a delay in treatment among AIS. Whether this contributes meaningful short-term outcome differences warranted further exploration.The objective study was evaluate impacts on and outcomes AIS treated IVT MT.Patients admitted before (from 11/1/2019 1/31/2020) 2/1/2020 3/31/2020) were screened for...

10.3389/fneur.2022.998758 article EN cc-by Frontiers in Neurology 2022-10-20

To investigate the efficacy and safety of bupivacaine liposome for pericapsular nerve group block (PENGB) postoperative analgesia in elderly patients with total hip replacement.

10.3760/cma.j.cn112137-20230810-00190 article EN PubMed 2024-01-16
Coming Soon ...